Omkar Pharmachem Intrinsic Value
OMKARPH • Chemicals
Current Stock Price
₹29.50
Primary Intrinsic Value
₹8.85
Market Cap
₹29.5 Cr
-70.0%
Downside
Median Value
₹8.85
Value Range
₹9 - ₹9
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
OMKARPH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹8.85 | ₹7.08 - ₹10.62 | -70.0% | EPS: ₹0.20, Sector P/E: 12x |
| Book Value Method | asset | ₹9.00 | ₹8.10 - ₹9.90 | -69.5% | Book Value/Share: ₹9.00, P/B: 1.0x |
| PEG Ratio Method | growth | ₹8.85 | ₹7.96 - ₹9.74 | -70.0% | EPS Growth: 2.7%, Fair P/E: 2.1x |
| Growth Adjusted P/E | growth | ₹8.85 | ₹7.96 - ₹9.74 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹8.85 | ₹7.96 - ₹9.74 | -70.0% | EPS: ₹0.20, BVPS: ₹9.00 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
OMKARPH Intrinsic Value Analysis
What is the intrinsic value of OMKARPH?
Based on our comprehensive analysis using 5 different valuation methods, the estimated intrinsic value of Omkar Pharmachem (OMKARPH) is ₹8.85 (median value). With the current market price of ₹29.50, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹8.85 to ₹9.00, indicating ₹8.85 - ₹9.00.
Is OMKARPH undervalued or overvalued?
Based on our multi-method analysis, Omkar Pharmachem (OMKARPH) appears to be trading above calculated value by approximately 70.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Debt to Equity Ratio | 1.11 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
Related Pages for Omkar Pharmachem
Additional stock information and data for OMKARPH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |